M-Modal could have fetched a higher price, analysts say

Not everyone is high on the news this week that JPMorgan Chase unit One Equity Partners acquired health technology vendor M-Modal for $1.1 billion. According to The Tennessean, many analysts have wondered why M-Modal sold for only $14 a share in cash.

"The question everybody's asking is what's there that we're missing?" analyst Leo Carpio told the newspaper. "Why are they selling themselves at so low a price?" Carpio said he thought the company could have been sold for at least $18 a share. Article

Suggested Articles

A healthcare non-profit wants to build a “moonshot factory” to bring data science and precision health to remote villages in the developing world.

Emory Healthcare in Atlanta is bringing the first 5G-enabled healthcare lab up online this week.

Federal regulators have listened to physicians' complaints about health IT burdens and they have some solutions.